A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors. (Q54649963)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors. |
scientific article |
Statements
1 reference
A comparison of the pharmacokinetics of the anticancer MET inhibitor foretinib free base tablet formulation to bisphosphate salt capsule formulation in patients with solid tumors. (English)
1 reference
Razelle Kurzrock
1 reference
Aung Naing
1 reference
Laurel M Adams
1 reference
Joseph F Kleha
1 reference
Kevin H Laubscher
1 reference
Peter L Bonate
1 reference
Steven Weller
1 reference
Colleen Fitzgerald
1 reference
Yanmei Xu
1 reference
Patricia M LoRusso
1 reference
15 September 2010
1 reference
1 reference
30
1 reference
327-334
1 reference
1
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference